Single User License
INR 272080
Site License
INR 544160
Corporate User License
INR 816240

Service Tax Additional

select a format
Price

Single User License
USD 4000
Site License
USD 8000
Corporate User License
USD 12000

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Injectable Drug Delivery-Medical Devices Pipeline Assessment, 2016

Injectable Drug Delivery-Medical Devices Pipeline Assessment, 2016


  Request for Sample Report

Executive Summary

Injectable Drug Delivery-Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Injectable Drug Delivery-Medical Devices Pipeline Assessment, 2016" provides an overview of Injectable Drug Delivery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Injectable Drug Delivery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Injectable Drug Delivery under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Injectable Drug Delivery and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons To Buy

The report enables you to

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Injectable Drug Delivery under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 11

1.2 List of Figures 19

2 Introduction 20

2.1 Injectable Drug Delivery Overview 20

3 Products under Development 21

3.1 Injectable Drug Delivery-Pipeline Products by Stage of Development 21

3.2 Injectable Drug Delivery-Pipeline Products by Segment 22

3.3 Injectable Drug Delivery-Pipeline Products by Territory 23

3.4 Injectable Drug Delivery-Pipeline Products by Regulatory Path 24

3.5 Injectable Drug Delivery-Pipeline Products by Estimated Approval Date 25

3.6 Injectable Drug Delivery-Ongoing Clinical Trials 26

4 Injectable Drug Delivery-Pipeline Products under Development by Companies 27

4.1 Injectable Drug Delivery Companies-Pipeline Products by Stage of Development 27

4.2 Injectable Drug Delivery-Pipeline Products by Stage of Development 31

5 Injectable Drug Delivery Companies and Product Overview 35

5.1 Aciont Inc. Company Overview 35

5.2 Actavis Inc. Company Overview 37

5.3 AdrenaCard, Inc. Company Overview 38

5.4 Allergan, Inc. Company Overview 39

5.5 Alsensa ApS Company Overview 40

5.6 AMAG Pharmaceuticals, Inc. Company Overview 41

5.7 Amgen Inc. Company Overview 43

5.8 Antares Pharma, Inc. Company Overview 45

5.9 Anterion Therapeutics, Inc. (Inactive) Company Overview 51

5.10 Arnali, LLC Company Overview 54

5.11 Artemes Technologies, Inc. Company Overview 55

5.12 AstraZeneca Plc Company Overview 56

5.13 Atanse, Inc. Company Overview 58

5.14 AzureBio, S.L. Company Overview 60

5.15 Becton, Dickinson and Company Company Overview 61

5.16 Bespak Europe Ltd. Company Overview 65

5.17 Biodel Inc. Company Overview 68

5.18 BioMarin Pharmaceutical Inc. Company Overview 70

5.19 BioRestorative Therapies, Inc. Company Overview 72

5.20 Boston University Company Overview 74

5.21 BTG Plc Company Overview 75

5.22 Burke Pharmaceuticals, LLC Company Overview 77

5.23 Callisyn Biomedical Inc Company Overview 78

5.24 Cambridge Consultants Limited Company Overview 81

5.25 Case Western Reserve University Company Overview 82

5.26 Cincinnati Children's Hospital Medical Center Company Overview 83

5.27 Clearside BioMedical, Inc. Company Overview 84

5.28 Consort Medical plc Company Overview 88

5.29 Credence MedSystems, Inc. Company Overview 89

5.30 CrossCoat Medical LLC Company Overview 90

5.31 Cytosial Biomedic, S.a.s. Company Overview 91

5.32 DALI Medical Devices Ltd. Company Overview 92

5.33 Delcath Systems, Inc. Company Overview 96

5.34 DelSite, Inc. (Inactive) Company Overview 101

5.35 Elcam Medical Company Overview 102

5.36 EmboMedics Company Overview 106

5.37 Emergent BioSolutions Inc. Company Overview 107

5.38 Eveon SAS Company Overview 109

5.39 Ghent University Company Overview 110

5.40 Hannover Medical School Company Overview 111

5.41 Indian Institute of Science Company Overview 112

5.42 Inovio Pharmaceuticals, Inc. Company Overview 113

5.43 LyoGo Company Overview 115

5.44 Medicom Innovation Partner a/s Company Overview 116

5.45 Meridian Medical Technologies, Inc. Company Overview 117

5.46 Mertiva AB Company Overview 118

5.47 Microchips Biotech, Inc. Company Overview 119

5.48 Midatech Pharma Plc Company Overview 121

5.49 Milestone Scientific Inc. Company Overview 123

5.50 North Carolina State University Company Overview 126

5.51 Ocelus Company Overview 128

5.52 Oval Medical Technologies Limited Company Overview 129

5.53 Particle Therapeutics Ltd Company Overview 130

5.54 Pfizer Inc. Company Overview 131

5.55 Portal Instruments, Inc. Company Overview 133

5.56 pSivida Corp. Company Overview 134

5.57 Ratio, Inc. Company Overview 139

5.58 Recon Therapeutics, LLC Company Overview 141

5.59 Replenish Inc Company Overview 142

5.60 RepliCel Life Sciences, Inc. Company Overview 144

5.61 RetinaPharma Technologies, Inc. Company Overview 145

5.62 Rx Safes, Inc. Company Overview 146

5.63 Scandinavian Health Ltd Company Overview 147

5.64 Shire Plc Company Overview 148

5.65 Spine Smith, LP Company Overview 150

5.66 Sun Pharmaceutical Industries Limited Company Overview 151

5.67 TCB medical devices Company Overview 153

5.68 Teva Pharmaceutical Industries Ltd. Company Overview 154

5.69 Texas Tech University Company Overview 156

5.70 TheraKine Ltd. (Inactive) Company Overview 157

5.71 Unilife Corporation Company Overview 159

5.72 United Therapeutics Corporation Company Overview 162

5.73 University College London Company Overview 164

5.74 University of Auckland Company Overview 165

5.75 University of Calgary Company Overview 166

5.76 University of California, Irvine Company Overview 167

5.77 University of California, San Diego Company Overview 168

5.78 University of California, San Francisco Company Overview 169

5.79 University of Delaware Company Overview 170

5.80 University of Dundee Company Overview 171

5.81 University of Florida Company Overview 172

5.82 University of Missouri Company Overview 175

5.83 University of Saskatchewan Company Overview 176

5.84 University of Texas at Austin Company Overview 177

5.85 Urodelia SA Company Overview 179

5.86 Vanderbilt University Company Overview 180

6 Injectable Drug Delivery- Recent Developments 181

6.1 Aug 29, 2016: Mylan to Launch First Generic to EpiPen Auto-Injector at a List Price of USD 300 per Two-Pack Carton, a More than 50% Discount to the Brand Product 181

6.2 Aug 29, 2016: pSivida Announces 13 New Patents Issued or Allowed 182

6.3 Aug 29, 2016: Catalent Reports Fourth Quarter and Fiscal Year 2016 Results 182

6.4 Aug 25, 2016: Mylan Taking Immediate Action To Further Enhance Access To EpiPen (Epinephrine Injection, USP) Auto-Injector 185

6.5 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 186

6.6 Aug 24, 2016: Senators Ask FDA to Account for Any Alternatives to the EpiPen Amid Product Cost Increases 188

6.7 Aug 24, 2016: Hillary Clinton Statement on EpiPen Pricing 189

6.8 Aug 24, 2016: Milestone Scientific Begins Transition From a Product Development to a Business Development Company 189

6.9 Aug 22, 2016: Mylan's Commitment to EpiPen (epinephrine injection, USP) Auto-Injector Access 190

6.10 Aug 17, 2016: Consort Medical Announces Directorate Change 191

6.11 Aug 16, 2016: Delcath Announces Second Quarter Financial Results 192

6.12 Aug 15, 2016: MRI Interventions Announces 2016 Second Quarter and Six Month Results 193

6.13 Aug 12, 2016: Milestone Scientific Reports 34% Increase in Revenue for the Second Quarter of 2016 197

6.14 Aug 11, 2016: Biodel Reports Third Quarter Fiscal Year 2016 Financial Results 198

6.15 Aug 11, 2016: Clearside Biomedical Reports Second Quarter 2016 Financial Results 198

6.16 Aug 09, 2016: Primary Endpoint Met in pSivida's Utilization Study of New Medidur Inserter with Smaller Diameter Needle 199

6.17 Aug 09, 2016: BioMarin Pharma Prices Public Offering of Shares for USD720 Million 200

6.18 Aug 09, 2016: Mylan Reports Strong Second Quarter 2016 Results Including Total Revenues Up 8% 200

6.19 Aug 09, 2016: Antares Pharma Reports Second Quarter 2016 Operating and Financial Results 203

6.20 Aug 09, 2016: Halozyme Reports Second Quarter 2016 Financial Results 205

6.21 Aug 05, 2016: Caverion delivers a Large Project for Novo Nordisk's new insulin production facility in Hillerod, Denmark 206

6.22 Aug 05, 2016: Novo Nordisk increased adjusted operating profit by 8% in local currencies in the first six months of 2016 207

6.23 Aug 04, 2016: Teva Reports Second Quarter 2016 Results 207

6.24 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 212

6.25 Aug 04, 2016: Merck Lifts Forecast Following Good Second Quarter 213

6.26 Aug 04, 2016: Emergent BioSolutions Reports Second Quarter and Six Months 2016 Financial Results 216

6.27 Aug 03, 2016: pSivida Names Dario Paggiarino, M.D. as Chief Medical Officer 219

6.28 Aug 02, 2016: Merck and Allergan May Acquire Biogen 219

6.29 Aug 02, 2016: Pfizer Reports Second-Quarter 2016 Results 219

6.30 Aug 02, 2016: Shire Delivers Strong Q2 2016 Revenue Growth; Upgrades Outlook 223

6.31 Aug 01, 2016: BCWorld Pharm Raises USD1.8 Million in Private Placement of Shares 228

6.32 Aug 01, 2016: Aptevo Therapeutics Completes Separation from Emergent BioSolutions 228

6.33 Aug 01, 2016: Clearside Biomedical Announces Promotion of Glenn Noronha, Ph.D. to Chief Scientific Officer and Jennifer M. Kissner, Ph.D. to Vice President, Clinical Development 228

6.34 Aug 01, 2016: Emergent BioSolutions Completes Spin-Off of Aptevo Therapeutics 229

7 Appendix 397

7.1 Methodology 397

7.2 About GlobalData 399

7.3 Contact Us 399

7.4 Disclaimer 400

1.2 List of Figures

Figure 1: Injectable Drug Delivery-Pipeline Products by Stage of Development 23

Figure 2: Injectable Drug Delivery-Pipeline Products by Segment 24

Figure 3: Injectable Drug Delivery-Pipeline Products by Territory 25

Figure 4: Injectable Drug Delivery-Pipeline Products by Regulatory Path 26

Figure 5: Injectable Drug Delivery-Pipeline Products by Estimated Approval Date 27

Figure 6: Injectable Drug Delivery-Ongoing Clinical Trials 28

1.1 List of Tables

Table 1: Injectable Drug Delivery-Pipeline Products by Stage of Development 23

Table 2: Injectable Drug Delivery-Pipeline Products by Segment 24

Table 3: Injectable Drug Delivery-Pipeline Products by Territory 25

Table 4: Injectable Drug Delivery-Pipeline Products by Regulatory Path 26

Table 5: Injectable Drug Delivery-Pipeline Products by Estimated Approval Date 27

Table 6: Injectable Drug Delivery-Ongoing Clinical Trials 28

Table 7: Injectable Drug Delivery Companies-Pipeline Products by Stage of Development 29

Table 8: Injectable Drug Delivery-Pipeline Products by Stage of Development 33

Table 9: Aciont Inc. Pipeline Products & Ongoing Clinical Trials Overview 37

Table 10: DSP-Visulex-Product Status 37

Table 11: DSP-Visulex-Product Description 38

Table 12: Visulex-I-Product Status 38

Table 13: Visulex-I-Product Description 38

Table 14: Actavis Inc. Pipeline Products & Ongoing Clinical Trials Overview 39

Table 15: Epinephrine Pre-Filled Syringe-Product Status 39

Table 16: Epinephrine Pre-Filled Syringe-Product Description 39

Table 17: AdrenaCard, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

Table 18: Adrenacard Auto-Injector-Product Status 40

Table 19: Adrenacard Auto-Injector-Product Description 40

Table 20: Allergan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41

Table 21: NOVADUR Intravitreal Implant-Product Status 41

Table 22: NOVADUR Intravitreal Implant-Product Description 41

Table 23: Alsensa ApS Pipeline Products & Ongoing Clinical Trials Overview 42

Table 24: SQJCT-Product Status 42

Table 25: SQJCT-Product Description 42

Table 26: AMAG Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43

Table 27: Makena Auto-Injector-Product Status 43

Table 28: Makena Auto-Injector-Product Description 44

Table 29: Amgen Inc. Pipeline Products & Ongoing Clinical Trials Overview 45

Table 30: Repatha Pushtronex System-Product Status 45

Table 31: Repatha Pushtronex System-Product Description 46

Table 32: Antares Pharma, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

Table 33: Teva Pen 1-Product Status 47

Table 34: Teva Pen 1-Product Description 48

Table 35: Vibex EPI-Product Status 48

Table 36: Vibex EPI-Product Description 48

Table 37: Vibex Mini-Needle Injectors-Product Status 49

Table 38: Vibex Mini-Needle Injectors-Product Description 49

Table 39: Vibex Qs-Next Generation Makena-Product Status 49

Table 40: Vibex Qs-Next Generation Makena-Product Description 50

Table 41: Vibex QS M-Product Status 50

Table 42: Vibex QS M-Product Description 50

Table 43: Vibex QS T-Product Status 51

Table 44: Vibex QS T-Product Description 51

Table 45: VIBEX Sumatriptan-Product Status 51

Table 46: VIBEX Sumatriptan-Product Description 52

Table 47: Anterion Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53

Table 48: Ambulin-Product Status 53

Table 49: Ambulin-Product Description 53

Table 50: Choless-Product Status 54

Table 51: Choless-Product Description 54

Table 52: Complimens-Product Status 54

Table 53: Complimens-Product Description 55

Table 54: Arnali, LLC Pipeline Products & Ongoing Clinical Trials Overview 56

Table 55: Arnali Drug Delivery Device-Product Status 56

Table 56: Arnali Drug Delivery Device-Product Description 56

Table 57: Artemes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57

Table 58: Artemes Magnetic Injection System-Product Status 57

Table 59: Artemes Magnetic Injection System-Product Description 57

Table 60: AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview 58

Table 61: Second Generation Bydureon Pen-Product Status 58

Table 62: Second Generation Bydureon Pen-Product Description 59

Table 63: Atanse, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60

Table 64: CEDSYS-Product Status 60

Table 65: CEDSYS-Product Description 60

Table 66: Intracerebral Microinjection Instrument-Product Status 61

Table 67: Intracerebral Microinjection Instrument-Product Description 61

Table 68: AzureBio, S.L. Pipeline Products & Ongoing Clinical Trials Overview 62

Table 69: Injectable Needle-Product Status 62

Table 70: Injectable Needle-Product Description 62

Table 71: Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview 63

Table 72: BD Libertas Patch Injector-Product Status 63

Table 73: BD Libertas Patch Injector-Product Description 64

Table 74: BD Physioject Disposable AutoInjector-Product Status 64

Table 75: BD Physioject Disposable AutoInjector-Product Description 64

Table 76: BD Simplist Prefilled Injectable-Heparin Sodium-Product Status 65

Table 77: BD Simplist Prefilled Injectable-Heparin Sodium-Product Description 65

Table 78: BD Simplist Prefilled Injectable-Hydromorphone Hydrochloride-Product Status 65

Table 79: BD Simplist Prefilled Injectable-Hydromorphone Hydrochloride-Product Description 66

Table 80: Bespak Europe Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67

Table 81: INJ570 Autoinjector-Product Status 67

Table 82: INJ570 Autoinjector-Product Description 67

Table 83: INJ650 ASI Auto-Injector-Product Status 68

Table 84: INJ650 ASI Auto-Injector-Product Description 68

Table 85: INJ700 Lila Mix Injector-Product Status 68

Table 86: INJ700 Lila Mix Injector-Product Description 69

Table 87: Biodel Inc. Pipeline Products & Ongoing Clinical Trials Overview 70

Table 88: EZMix Glucagon Rescue Device-Product Status 70

Table 89: EZMix Glucagon Rescue Device-Product Description 71

Table 90: BioMarin Pharmaceutical Inc. Pipeline Products & Ongoing Clinical Trials Overview 72

Table 91: PEG PAL Pre-filled Syringe-Product Status 72

Table 92: PEG PAL Pre-filled Syringe-Product Description 73

Table 93: BioRestorative Therapies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74

Table 94: brtxDISC Stem Cell Delivery Device-Product Status 74

Table 95: brtxDISC Stem Cell Delivery Device-Product Description 75

Table 96: Boston University Pipeline Products & Ongoing Clinical Trials Overview 76

Table 97: Polymeric Drug Delivery System-Product Status 76

Table 98: Polymeric Drug Delivery System-Product Description 76

Table 99: BTG Plc Pipeline Products & Ongoing Clinical Trials Overview 77

Table 100: Varithena-Product Status 77

Table 101: Varithena-Product Description 78

Table 102: Varithena-Aesthetic Leg Veins-Product Status 78

Table 103: Varithena-Aesthetic Leg Veins-Product Description 78

Table 104: Burke Pharmaceuticals, LLC Pipeline Products & Ongoing Clinical Trials Overview 79

Table 105: BURKE201 Needle Injection Pen-Product Status 79

Table 106: BURKE201 Needle Injection Pen-Product Description 79

Table 107: Callisyn Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 80

Table 108: 8Spheres Embolic Microspheres-Product Status 80

Table 109: 8Spheres Embolic Microspheres-Product Description 81

Table 110: Callispheres PVA Embolic Microspheres-Product Status 81

Table 111: Callispheres PVA Embolic Microspheres-Product Description 81

Table 112: TACEspheres Drug Eluting Embolic Microspheres-Product Status 82

Table 113: TACEspheres Drug Eluting Embolic Microspheres-Product Description 82

Table 114: Cambridge Consultants Limited Pipeline Products & Ongoing Clinical Trials Overview 83

Table 115: Flexi-ject-Product Status 83

Table 116: Flexi-ject-Product Description 83

Table 117: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 84

Table 118: Pressure Driven Local Drug Delivery System-Liver Cancer-Product Status 84

Table 119: Pressure Driven Local Drug Delivery System-Liver Cancer-Product Description 84

Table 120: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 85

Table 121: Pre-Filled Syringe With Flush-Product Status 85

Table 122: Pre-Filled Syringe With Flush-Product Description 85

Table 123: Clearside BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86

Table 124: SCS Microinjector-Product Status 86

Table 125: SCS Microinjector-Product Description 87

Table 126: Clearside BioMedical, Inc.-Ongoing Clinical Trials Overview 88

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Aciont Inc.

Actavis Inc.

AdrenaCard, Inc.

Allergan, Inc.

Alsensa ApS

AMAG Pharmaceuticals, Inc.

Amgen Inc.

Antares Pharma, Inc.

Anterion Therapeutics, Inc.

Arnali, LLC

Artemes Technologies, Inc.

AstraZeneca Plc

Atanse, Inc.

AzureBio, S.L.

Becton, Dickinson and Company

Bespak Europe Ltd.

Biodel Inc.

BioMarin Pharmaceutical Inc.

BioRestorative Therapies, Inc.

Boston University

BTG Plc

Burke Pharmaceuticals, LLC

Callisyn Biomedical Inc

Cambridge Consultants Limited

Case Western Reserve University

Cincinnati Children's Hospital Medical Center

Clearside BioMedical, Inc.

Consort Medical plc

Credence MedSystems, Inc.

CrossCoat Medical LLC

Cytosial Biomedic, S.a.s.

DALI Medical Devices Ltd.

Delcath Systems, Inc.

DelSite, Inc.

Elcam Medical

EmboMedics

Emergent BioSolutions Inc.

Eveon SAS

Ghent University

Hannover Medical School

Indian Institute of Science

Inovio Pharmaceuticals, Inc.

LyoGo

Medicom Innovation Partner a/s

Meridian Medical Technologies, Inc.

Mertiva AB

Microchips Biotech, Inc.

Midatech Pharma Plc

Milestone Scientific Inc.

North Carolina State University

Ocelus

Oval Medical Technologies Limited

Particle Therapeutics Ltd

Pfizer Inc.

Portal Instruments, Inc.

pSivida Corp.

Ratio, Inc.

Recon Therapeutics, LLC

Replenish Inc

RepliCel Life Sciences, Inc.

RetinaPharma Technologies, Inc.

Rx Safes, Inc.

Scandinavian Health Ltd

Shire Plc

Spine Smith, LP

Sun Pharmaceutical Industries Limited

TCB medical devices

Teva Pharmaceutical Industries Ltd.

Texas Tech University

TheraKine Ltd.

Unilife Corporation

United Therapeutics Corporation

University College London

University of Auckland

University of Calgary

University of California, Irvine

University of California, San Diego

University of California, San Francisco

University of Delaware

University of Dundee

University of Florida

University of Missouri

University of Saskatchewan

University of Texas at Austin

Urodelia SA

Vanderbilt University

Aciont Inc., DSP-Visulex; Aciont Inc., Visulex-I; Actavis Inc., Epinephrine Pre-Filled Syringe; AdrenaCard, Inc., Adrenacard Auto-Injector; Allergan, Inc., NOVADUR Intravitreal Implant; Alsensa ApS, SQJCT; AMAG Pharmaceuticals, Inc., Makena Auto-Injector; Amgen Inc., Repatha Pushtronex System; Antares Pharma, Inc., Teva Pen 1; Antares Pharma, Inc., Vibex EPI; Antares Pharma, Inc., Vibex Mini-Needle Injectors; Antares Pharma, Inc., Vibex Qs-Next Generation Makena; Antares Pharma, Inc., Vibex QS M; Antares Pharma, Inc., Vibex QS T; Antares Pharma, Inc., VIBEX Sumatriptan; Anterion Therapeutics, Inc. (Inactive), Ambulin; Anterion Therapeutics, Inc. (Inactive), Choless; Anterion Therapeutics, Inc. (Inactive), Complimens; Arnali, LLC, Arnali Drug Delivery Device; Artemes Technologies, Inc., Artemes Magnetic Injection System; AstraZeneca Plc, Second Generation Bydureon Pen; Atanse, Inc., CEDSYS; Atanse, Inc., Intracerebral Microinjection Instrument; AzureBio, S.L., Injectable Needle; Becton, Dickinson and Company, BD Libertas Patch Injector; Becton, Dickinson and Company, BD Physioject Disposable AutoInjector; Becton, Dickinson and Company, BD Simplist Prefilled Injectable-Heparin Sodium; Becton, Dickinson and Company, BD Simplist Prefilled Injectable-Hydromorphone Hydrochloride; Bespak Europe Ltd., INJ570 Autoinjector; Bespak Europe Ltd., INJ650 ASI Auto-Injector; Bespak Europe Ltd., INJ700 Lila Mix Injector; Biodel Inc., EZMix Glucagon Rescue Device; BioMarin Pharmaceutical Inc., PEG PAL Pre-filled Syringe; BioRestorative Therapies, Inc., brtxDISC Stem Cell Delivery Device; Boston University, Polymeric Drug Delivery System; BTG Plc, Varithena; BTG Plc, Varithena-Aesthetic Leg Veins; Burke Pharmaceuticals, LLC, BURKE201 Needle Injection Pen; Callisyn Biomedical Inc, 8Spheres Embolic Microspheres; Callisyn Biomedical Inc, Callispheres PVA Embolic Microspheres; Callisyn Biomedical Inc, TACEspheres Drug Eluting Embolic Microspheres; Cambridge Consultants Limited, Flexi-ject; Case Western Reserve University, Pressure Driven Local Drug Delivery System-Liver Cancer; Cincinnati Children's Hospital Medical Center, Pre-Filled Syringe With Flush; Clearside BioMedical, Inc., SCS Microinjector; Consort Medical plc, INJ200 Autoinjector; Credence MedSystems, Inc., Credence Companion Safety Syringe System; CrossCoat Medical LLC, CCM-D; Cytosial Biomedic, S.a.s., Vaccine Delivery Device; DALI Medical Devices Ltd., SAN-DV; DALI Medical Devices Ltd., SAN-DV Pro; DALI Medical Devices Ltd., SAN-L; DALI Medical Devices Ltd., SAN-Light Premium Safety Needle; DALI Medical Devices Ltd., SAN-P; Delcath Systems, Inc., Delcath Hepatic CHEMOSAT Delivery System; DelSite, Inc. (Inactive), GelSure; Elcam Medical, Flexi-Q eMU; Elcam Medical, Flexi-Q HV; Elcam Medical, Flexi-Q mMU; Elcam Medical, Flexi-Q PFS; EmboMedics, EmboMedics Microspheres; Emergent BioSolutions Inc., Emergard; Eveon SAS, Automatic Injection Device; Ghent University, Poly-electrolyte Micropartcle (PEM) System; Hannover Medical School, I-Gun; Indian Institute of Science, Needleless Drug Delivery Device; Inovio Pharmaceuticals, Inc., Iject Pre-Filled Syringe; Inovio Pharmaceuticals, Inc., Jupiter Jet; LyoGo, QuickStick; Medicom Innovation Partner a/s, Intelligent Auto Injector; Meridian Medical Technologies, Inc., Midazolam Auto-Injector; Mertiva AB, Nerve Targeting Drug Delivery System; Microchips Biotech, Inc., Microchip-Based Implant; Midatech Pharma Plc, Q-Sphera; Milestone Scientific Inc., CompuFlo System; Milestone Scientific Inc., Intra-Articular Drug Delivery System; Milestone Scientific Inc., Self-Administered Drug Delivery Device; North Carolina State University, ATP-Triggered Drug Delivery System; Ocelus, Ocelus Microimplant Delivery System; Oval Medical Technologies Limited, Oval Autoinjector; Particle Therapeutics Ltd, PRT Glucagon Device; Pfizer Inc., Sayana Press-Self Administration; Portal Instruments, Inc., Computerized Needle-free Drug Delivery System; pSivida Corp., Durasert Latanoprost Implant; pSivida Corp., Medidur; pSivida Corp., Tethadur System; Ratio, Inc., NuPrivo-ID; Ratio, Inc., NuPrivo-SC; Recon Therapeutics, LLC, LyoKit; Replenish Inc, MicroPump System; RepliCel Life Sciences, Inc., RCI-02 Injector; RetinaPharma Technologies, Inc., PhotoTarget Drug Delivery System; Rx Safes, Inc., Rx MyDOSE; Scandinavian Health Ltd, Pen Injector-Transcutaneous Pulmonary Delivery; Shire Plc, Injectable Pen Device-Natpara; Spine Smith, LP, Proprietary Disc Injection Device; Sun Pharmaceutical Industries Limited, Somatostatin Analogue Microspheres; TCB medical devices, Epinephrine Auto-Injector Key; Teva Pharmaceutical Industries Ltd., BYETTA; Teva Pharmaceutical Industries Ltd., Injectable Device; Texas Tech University, Minimally-Invasive Intratumoral Drug Delivery Needle; TheraKine Ltd. (Inactive), AngioKine; TheraKine Ltd. (Inactive), OptiKine; Unilife Corporation, Ocu-ject; Unilife Corporation, Unifill Finesse; Unilife Corporation, Unifill Select; United Therapeutics Corporation, Synchromed II Implantable Pump-Remodulin; United Therapeutics Corporation, Unity Remodulin; University College London, Cisplatin Delivery System; University of Auckland, High-Pressure Needle-Less Device; University of Calgary, Painless Drug Delivery Device; University of California, Irvine, Painless Injection Device; University of California, San Diego, Spinal Injection Device; University of California, San Francisco, Drug Delivery Cannula System; University of Delaware, Implantable Drug Delivery Device; University of Dundee, Multipoint Injector; University of Florida, Drug Delivery System-Autoimmune Diseases; University of Florida, Drug Delivery System-Type 1 Diabetes; University of Florida, MEMS Device; University of Missouri, Intravitreal Injection Device; University of Saskatchewan, Auto-Injector System; University of Texas at Austin, In-Situ Cross-Linkable Hydrogel; University of Texas at Austin, Nanofabricated Drug Delivery Device; Urodelia SA, APAVAC Kit; Vanderbilt University, Aliquot Delivery System


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com